ATE195122T1 - Verbindungen vom chinolizinon-typ - Google Patents
Verbindungen vom chinolizinon-typInfo
- Publication number
- ATE195122T1 ATE195122T1 AT91909628T AT91909628T ATE195122T1 AT E195122 T1 ATE195122 T1 AT E195122T1 AT 91909628 T AT91909628 T AT 91909628T AT 91909628 T AT91909628 T AT 91909628T AT E195122 T1 ATE195122 T1 AT E195122T1
- Authority
- AT
- Austria
- Prior art keywords
- loweralkyl
- group
- loweralkoxy
- amino
- formula
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 6
- 229910052736 halogen Inorganic materials 0.000 abstract 5
- 125000001475 halogen functional group Chemical group 0.000 abstract 5
- 150000002367 halogens Chemical class 0.000 abstract 5
- 229910052739 hydrogen Inorganic materials 0.000 abstract 5
- 239000001257 hydrogen Substances 0.000 abstract 5
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 5
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 3
- 125000004356 hydroxy functional group Chemical group O* 0.000 abstract 2
- 229910052757 nitrogen Inorganic materials 0.000 abstract 2
- 229910052760 oxygen Inorganic materials 0.000 abstract 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
- 229910052717 sulfur Inorganic materials 0.000 abstract 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 1
- 150000001408 amides Chemical class 0.000 abstract 1
- 125000004429 atom Chemical group 0.000 abstract 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- 150000001602 bicycloalkyls Chemical group 0.000 abstract 1
- 150000001768 cations Chemical class 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 125000000392 cycloalkenyl group Chemical group 0.000 abstract 1
- 125000004185 ester group Chemical group 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 229940002612 prodrug Drugs 0.000 abstract 1
- 239000000651 prodrug Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229920006395 saturated elastomer Polymers 0.000 abstract 1
- 125000004434 sulfur atom Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/68—One oxygen atom attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
- C07D455/02—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing not further condensed quinolizine ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- Communicable Diseases (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Saccharide Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US51778090A | 1990-05-02 | 1990-05-02 | |
| PCT/US1991/002998 WO1991016894A1 (en) | 1990-05-02 | 1991-05-01 | Quinolizinone type compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE195122T1 true ATE195122T1 (de) | 2000-08-15 |
Family
ID=24061202
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT91909628T ATE195122T1 (de) | 1990-05-02 | 1991-05-01 | Verbindungen vom chinolizinon-typ |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP0527889B1 (de) |
| JP (1) | JP2514136B2 (de) |
| AT (1) | ATE195122T1 (de) |
| CA (1) | CA2081891C (de) |
| DE (1) | DE69132348T2 (de) |
| DK (1) | DK0527889T3 (de) |
| ES (1) | ES2150904T3 (de) |
| GR (1) | GR3034694T3 (de) |
| IE (1) | IE911472A1 (de) |
| WO (1) | WO1991016894A1 (de) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5726182A (en) * | 1990-05-02 | 1998-03-10 | Abbott Laboratories | Quinolizinone type compounds |
| US5252747A (en) * | 1992-09-11 | 1993-10-12 | Abbott Laboratories | Chiral quinolone intermediates |
| ATE217309T1 (de) * | 1993-10-14 | 2002-05-15 | Abbott Lab | Verbindungen des chinolizinon-typs |
| RU2140919C1 (ru) * | 1994-07-18 | 1999-11-10 | Убе Индастриз Лтд. | Производные 8-трифторметилхинолинкарбоновой кислоты, фармацевтическая композиция и способ ингибирования вируса иммунодефицита |
| US5618813A (en) * | 1995-05-26 | 1997-04-08 | Abbott Laboratories | Benzo[5.6]pyrano[2.3.4-ij]quinolizine and benzo[5.6]thiopyrano[2.3.4-ij]quinolizine derivatives as antibacterial and antineoplastic agents |
| AU6153096A (en) * | 1995-06-06 | 1996-12-24 | Abbott Laboratories | Quinolizinone type compounds |
| US5703244A (en) * | 1996-11-21 | 1997-12-30 | Abbott Laboratories | Process for preparation of chiral 3-amino-pyrrolidine and analogous bicyclic compounds |
| US5693813A (en) * | 1997-02-26 | 1997-12-02 | Abbott Laboratories | Process for preparation of 4H-4-oxo-quinolizine-3-carboxylic acid |
| PE128799A1 (es) | 1997-09-15 | 2000-02-17 | Procter & Gamble | Quinolinas antimicrobianas y sus composiciones |
| US6630488B1 (en) | 1998-09-21 | 2003-10-07 | Biochem Pharma, Inc. | Quinolizinones as integrin inhibitors |
| US6197974B1 (en) | 1998-10-26 | 2001-03-06 | Abbott Laboratories | Enantioselective synthesis of 3-aminopyrrolidines |
| AU2001286191A1 (en) * | 2000-09-12 | 2002-03-26 | Sankyo Company, Limited | Quinolizine derivatives |
| AU3089102A (en) | 2000-12-14 | 2002-06-24 | Procter & Gamble | Antimicrobial quinolones |
| WO2002048143A2 (en) * | 2000-12-14 | 2002-06-20 | The Procter & Gamble Company | Antimicrobial 2-pyridones, their compositions and uses |
| WO2006033422A1 (ja) * | 2004-09-21 | 2006-03-30 | Japan Tobacco Inc. | キノリジノン化合物、およびそのｈｉｖインテグラーゼ阻害剤としての利用 |
| US7745459B2 (en) | 2004-09-21 | 2010-06-29 | Japan Tobacco Inc. | Quinolizinone compound and use thereof as HIV integrase inhibitor |
| US7456279B2 (en) | 2006-03-28 | 2008-11-25 | The Procter & Gamble Company | Coupling process for preparing quinolone intermediates |
| PL2001862T3 (pl) | 2006-03-28 | 2011-09-30 | Warner Chilcott Co Llc | Jabłczany oraz odmiany polimorficzne kwasu (3S,5S)-7-[3-amino-5-metylo-piperydynylo]-1-cyklopropylo-1,4-dihydro-8-metoksy-4-okso-3-chinolinokarboksylowego |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2358891A1 (fr) * | 1976-07-22 | 1978-02-17 | Yamanouchi Pharma Co Ltd | Composes heterocycliques contenant un azote, utilise comme agents analgesiques et anti-inflammatoires |
| HU178910B (en) * | 1977-08-19 | 1982-07-28 | Chinoin Gyogyszer Es Vegyeszet | Process for preparing 2,3-disubstituted-4-oxo-4h-pyrido/1,2-a/-pyrimidines |
| JPS57203085A (en) * | 1981-06-09 | 1982-12-13 | Dai Ichi Seiyaku Co Ltd | 1,8-cyclic substituted quinoline derivative |
| GB8408292D0 (en) * | 1984-03-30 | 1984-05-10 | Fujisawa Pharmaceutical Co | Quinolizinone compound |
| US4650804A (en) * | 1984-03-30 | 1987-03-17 | Fujisawa Pharmaceutical Co., Ltd. | Quinolizinone compounds and pharmaceutical composition comprising the same, useful as anti-ulcerative and anti-allergic agents |
| US4571396A (en) * | 1984-04-16 | 1986-02-18 | Warner-Lambert Company | Antibacterial agents |
| DE3517535A1 (de) * | 1985-05-15 | 1986-11-20 | Bayer Ag, 5090 Leverkusen | 1-aryl-4-chinolon-3-carbonsaeuren |
| JPS6277385A (ja) * | 1985-08-30 | 1987-04-09 | Fujisawa Pharmaceut Co Ltd | キノリジノン化合物、その製造法およびそれを含有する医薬組成物 |
| EP0224121A3 (de) * | 1985-11-19 | 1987-11-11 | ROTTAPHARM S.p.A. | 7-[4-Aminopiperazinyl]- oder 7-[4-Chlorpiperazinyl]chinolinonderivate,Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zusammensetzungen |
| US4877795A (en) * | 1987-01-30 | 1989-10-31 | Kissei Pharmaceutical Co., Ltd. | 4H-quinolizin-4-one compounds useful for the treatment of allergic bronchial asthma, allergic rhinitis atropic dermatitis and the like |
| US4921857A (en) * | 1987-09-18 | 1990-05-01 | Merck & Co., Inc. | 4-Oxo-4h-quinolizine-3-carboxylic acids and derivatives thereof |
| NZ232091A (en) * | 1989-01-16 | 1990-12-21 | Bellon Labor Sa Roger | 7-fluoro-8-(piperazin-1-yl)-4-oxo-1,4-dihydro-benzo(b)(1,8)naphthyridine-3-carboxylic acid derivatives, preparation and pharmaceutical compositions thereof |
-
1991
- 1991-05-01 ES ES91909628T patent/ES2150904T3/es not_active Expired - Lifetime
- 1991-05-01 WO PCT/US1991/002998 patent/WO1991016894A1/en not_active Ceased
- 1991-05-01 CA CA002081891A patent/CA2081891C/en not_active Expired - Fee Related
- 1991-05-01 DE DE69132348T patent/DE69132348T2/de not_active Expired - Fee Related
- 1991-05-01 EP EP91909628A patent/EP0527889B1/de not_active Expired - Lifetime
- 1991-05-01 DK DK91909628T patent/DK0527889T3/da active
- 1991-05-01 JP JP3509157A patent/JP2514136B2/ja not_active Expired - Lifetime
- 1991-05-01 IE IE147291A patent/IE911472A1/en not_active Application Discontinuation
- 1991-05-01 AT AT91909628T patent/ATE195122T1/de not_active IP Right Cessation
-
2000
- 2000-10-27 GR GR20000402381T patent/GR3034694T3/el not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP0527889A1 (de) | 1993-02-24 |
| EP0527889A4 (en) | 1994-08-10 |
| CA2081891A1 (en) | 1991-11-03 |
| DE69132348D1 (de) | 2000-09-07 |
| CA2081891C (en) | 1999-03-16 |
| JPH05503709A (ja) | 1993-06-17 |
| DK0527889T3 (da) | 2000-12-18 |
| GR3034694T3 (en) | 2001-01-31 |
| IE911472A1 (en) | 1991-11-06 |
| WO1991016894A1 (en) | 1991-11-14 |
| DE69132348T2 (de) | 2001-03-15 |
| ES2150904T3 (es) | 2000-12-16 |
| EP0527889B1 (de) | 2000-08-02 |
| JP2514136B2 (ja) | 1996-07-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE195122T1 (de) | Verbindungen vom chinolizinon-typ | |
| DK584886D0 (da) | Vanduoplaeselige, mono- og disubstituerede derivater af rapamycin og farmaceutisk acceptable salte deraf | |
| EA200100135A1 (ru) | Алкинилзамещенные производные хинолин-2-она, полезные в качестве противораковых агентов | |
| ATE141263T1 (de) | Pharmazeutisch wirksame zns-verbindung | |
| ATE51402T1 (de) | Infrarot-absorber. | |
| MY131297A (en) | Herbicides | |
| MX9206939A (es) | Derivados de piperazina, procedimiento para su preparacion y composicion farmaceutica que los comprende | |
| HU9402239D0 (en) | Isoxazole-derivatives, compositions containing them and processes for their preparation | |
| ES474215A1 (es) | Procedimiento para la preparacion de derivados imidazolile- tiloxialcoxilicos y sus analogos con agrupacion tio | |
| DK615984A (da) | Spiro-bundne pyrrolidin-2,5-dioner og baseadditionssalte deraf samt fremgangsmaade til fremstilling af saadanne forbindelser | |
| SE7712630L (sv) | Forfarande for framstellning av o-alkylerade hydroxylaminer | |
| SE8601826D0 (sv) | 5-pyrimidinecarboxamides and treatment of leukemia and tumors therewith | |
| DK384485D0 (da) | 1,6-naphthyridinderivater med kardilaterende virkning | |
| DE69116392D1 (de) | Benzosoxazolderivate | |
| FR2552083B1 (fr) | Derives de (alkynyloxy-3 hydroxy-2-propyl)-4 piperazinyl-1 n-phenyl acetamide, leur preparation et leur application en therapeutique | |
| MA19966A1 (fr) | Nouveaux derives de la pyrrolidine et leur preparation | |
| MX15697A (es) | Derivados heterotetraciclicos de lactama y procesopara su preparacion | |
| ATE960T1 (de) | Derivate von 2-benzoyl-4-nitro-aniliden, deren herstellung und deren verwendung als heilmittel. | |
| GR3019921T3 (en) | Alkylaminoalkylamino and -ether compounds as well as processes and intermediates for their preparation, and medicaments containing these compounds | |
| DK182181A (da) | Antihypertensivt virksomme lactamer og fremgangsmaade til fremstilling heraf | |
| NO933478L (no) | 6-heterocyklisk-4-amino-1,2,2a,3,4,5-heksahydrobenz(CD)indoler for behandling av reisesyke og oppkast | |
| ATE14314T1 (de) | 7-beta-(ketooximinoacylamido)-ceph-3-em-4carbons|urederivate, verfahren zur herstellung derselben und diese enthaltende arzneimittel. | |
| ATE150753T1 (de) | 1'-amino-2((benzothiazolyl)methyl> spiro (isochinolin-4(1h), 3'-pyrrolidine>-1,2',3,5'- tetrone und analoge davon verwendbar als aldosereduktase luhibitoren |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |